Objectives: - Clinical applications of PLLA in combination with other treatment modalities for facial and body rejuvenation, as well as scars.

Objectives: To identify the cheekbones and jawlines as two parallel lines ("snatched lines") which can be treated simultaneously to create balance and overall improvement of facial features.

To be aware of the anatomic considerations of the cheekbones and jawline relevant to injectable treatments.

To learn how to safely and effectively combine therapies (fillers, threads and toxin) in order to treat these areas.

Objectives: The most promising areas for facial rejuvenation are the frontal and temporal areas.
Involution changes affect the frontal and temporal zones following fat packets involution, ptosis, retraction of temporal zone.

Introduction: The procedures of facial countering often need to start with the upper third of face.

Materials / method: This review is based on the authors clinical experience in treating the temporal and frontal areas for aesthetic purposes.

Results: The frontal area consists of 5 layers. The safest layer for injections of hyaluronic acid fillers is the supraperirest level. There are 10 layers in the temporal zone, and the safest method is an interfactional injection.
The report presents techniques of correction of the temporal and frontal areas to increase the volume and obtain the lifting effect, as well as techniques of the suspension lifting.

Conclusion: This report provides a detailed anatomical overview of the temple and forehead areas, describing safe injection techniques from an anatomical and aesthetic result perspective, as well as methods to avoidя unwanted effects during facial rejuvenation.

Declaraciones

¿Ha recibido algún tipo de financiamiento para realizar su investigación sobre esta temática?
Si
Por favor especifique las entidades (individuo, empresa, sociedad): Ipsen. Siam2024 . ECLM2024. PRO AGELESS 2023.

¿Ha recibido algún pago, honorario u otra compensación por su trabajo acerca de esta investigación?
Si
Por favor especifique las entidades (individuo, empresa, sociedad): Ipsen. Siam2024 . ECLM2024. PRO AGELESS 2023.

¿Tiene vínculos financieros con alguna entidad que podría llegar a competir estrechamente con los medicamentos, materiales o instrumentos tratados en su investigación?
No

¿Posee o ha solicitado una patente relacionada a los materiales, productos o instrumentos utilizados en su investigación?
No

Este trabajo no cuenta con el apoyo de ningún financiamiento directo o indirecto. El autor asume plena responsabilidad sobre el mismo.